Fibrodysplasia Ossificans Progressiva: Difference between revisions

No edit summary
No edit summary
Line 177: Line 177:
'''Henry Eastlack Skeleton '''<br> Henry Eastlack was a gentlemen who suffered and died from FOP. His&nbsp;<span style="line-height: 1.5em; font-size: 13.28px;">skeleton&nbsp;is now on display at The Mutter Museum of The College of&nbsp;</span>Physicians in Philadelphia. When individuals die their skeleton falls apart because&nbsp;the connective tissue, ligaments and tendons are no longer holding their&nbsp;skeleton together. When a skeleton is put on display at a museum it has to&nbsp;meticulously be rearticulated with wires and glue. Henry's skeleton never had&nbsp;to be rearticulated becuase of the extra bone created by FOP. &nbsp;His skeleton&nbsp;truly&nbsp;shows the harsh reality of FOP&nbsp;and the dysfunctions it can create.<ref name="IFOP" />  
'''Henry Eastlack Skeleton '''<br> Henry Eastlack was a gentlemen who suffered and died from FOP. His&nbsp;<span style="line-height: 1.5em; font-size: 13.28px;">skeleton&nbsp;is now on display at The Mutter Museum of The College of&nbsp;</span>Physicians in Philadelphia. When individuals die their skeleton falls apart because&nbsp;the connective tissue, ligaments and tendons are no longer holding their&nbsp;skeleton together. When a skeleton is put on display at a museum it has to&nbsp;meticulously be rearticulated with wires and glue. Henry's skeleton never had&nbsp;to be rearticulated becuase of the extra bone created by FOP. &nbsp;His skeleton&nbsp;truly&nbsp;shows the harsh reality of FOP&nbsp;and the dysfunctions it can create.<ref name="IFOP" />  


[[Image:Fibrodysplasia ossificans progressiva.jpg|thumb|right|250x300px|Fibrodysplasia Ossificans Progressiva]]
[[Image:Fibrodysplasia ossificans progressiva.jpg|thumb|left|250x300px|Fibrodysplasia Ossificans Progressiva]]


== Recent Related Research (from [http://www.ncbi.nlm.nih.gov/pubmed/ Pubmed])  ==
== Recent Related Research (from [http://www.ncbi.nlm.nih.gov/pubmed/ Pubmed])  ==

Revision as of 23:04, 5 April 2016

 

Welcome to <a href="Pathophysiology of Complex Patient Problems">PT 635 Pathophysiology of Complex Patient Problems</a> This is a wiki created by and for the students in the School of Physical Therapy at Bellarmine University in Louisville KY. Please do not edit unless you are involved in this project, but please come back in the near future to check out new information!!

Original Editors - <a href="Pathophysiology of Complex Patient Problems">Carly McArtor and Krista Polanin from Bellarmine University's Pathophysiology of Complex Patient Problems project.</a>

Top Contributors - <img _fck_mw_template="true" _fckrealelement="1" _fckfakelement="true" src="http://www.physio-pedia.com/extensions/FCKeditor/fckeditor/editor/images/spacer.gif" class="FCK__MWTemplate">  

Definition/Description[edit | edit source]

Fibrodysplasia Ossificans Progressiva is a rare, genetic disorder that transforms ligaments, muscles and tendons into bone outside the skeleton that impairs movement.[1] It was first described in 1692 and is characterized by progressive heterotropic ossification in anatomic structures. [2]At first it was given the name Myositis Ossificans Progressiva which means "muscle that turns to bone." [2]The name was later changed to Fibrodysplasia Ossificans Progressiva indicating "soft tissue that turns to bone." [2]The name Fibrodysplasia Ossificans Progressiva means that ligaments and tendons are also turning to bone not just muscle which differentiates it from Myositis Ossificans Progressiva.[2]This difference was discovered by Dr. Victor McKusick of Johns Hopkins University in the 1970's. [2]

Prevalence[edit | edit source]

  • 1 in every 2 million people are diagnosed with Fibrodysplasia Ossificans Porgressiva[1]
  • Nearly 90% of the time it is misdiagnosed and mismanaged.[1]
  • 67% undergo invasive procedures for diagnosis and treatment[1]
  • Mostly begins in childhood, usually diagnosed before age 10[2]
  • It has not been shown to be linked with any specific gender, ethnicity or race[2]
  • There have been 800 confirmed cases in the world and 285 in the United States[2] 


Characteristics/Clinical Presentation[edit | edit source]

  • Congenital hallux valgus with microdactyly and monophalangeal great toe are early signs that are often visible at birth.[1]
  • FOP primarily starts at the neck and shoulders then progressively moves to the trunk, back and extremities once the extra bone begins to form.[1]
  • Ossification of intercostal muscles[3]                                         
  • Kyphoscoliosis and lordosis[4]
  • Severe weight loss[1]
  • Torticollis[5]
  • TMJ complications[4]

Flare-ups are usually sporadic and unpredictable. It is impossible to predict duration and severity of the flare-ups even though there has been some characteritic patterns described in some research. It is also possible that flare-ups can occur from trauma.[3]

  • Acute flare-ups due to: intramuscular immunizations, mandibular blocks for dental work, muscle fatigue, blunt muscle trauma from bumps, bruises, falls, influenza-like viral illnesses[3]
Hallux Valgus

Prognosis

  • The average lifespan of these patients is approximately 40 years. Death is usually caused by respiratory infections.[2]
  • Most individuals with FOP are confined to a wheelchair by the second decade of life.[6]
  • More than 50% will experience lifelong diabilities.[6]

Medications[edit | edit source]

For acute flare-ups:

  • Short term high does corticosteroids[1]
  • NSAIDS[1]
  • Biophosphonates[1]
  • Radiotherapy[1] 

For chronic discomfort and ongoing flare-ups:

  • Cyclo-oxygenase-2 inhibitors[3]
  • Leukotreine inhibitors[3]
  • Mast Cell Stabilizers[3]

Diagnostic Tests/Lab Tests/Lab Values[edit | edit source]

Fibrodysplasia Ossificans Progressiva can be misdiagnosed easily, but can be avoided by examining the individual's toes for the hallux valgus and the short great toe feature, along with a thorough clinical examination and a positive test for the ACVR1 gene.[4] Genetic testing can now be done to confirm the diagnosis of FOP prior to the appearance of heterotropic ossification, which may avoid possible treatments and diagnostic testing.[3]  

Blood Samples

Ossification lower ribs
  • Positive for heterozygous R206H mutation of the ACVR1 gene.[1]


Computed Tomography[1]

Magnetic Resonance Imaging[1]

Bone Scans[1]

ESR elevated during acute flare-ups[1]

Etiology/Causes[edit | edit source]

  • Genetic R206H mutation of the ACVR1 gene[1]
  • ACVR1 gene is a bone morphogenetic protein (BMP) type1 receptor signaling endochondral ossification[1]
  • R206H mutation leads to an increase in enhanced BMP signaling[1]
  • Confirmation of a heterozygous gene mutation of the ACVR1 gene[1]

Systemic Involvement[edit | edit source]

Cardiopulmonary system

  • Respiratoy problems caused by thoracic insufficiencies (i.e. decreased chest wall expansion)[4]
  • Throacic Insufficieny Syndrome, a possible life-threating complication that can cause right sided heart failure and pneumonia. Maximizing pulmonary function and minimizing respiratory complications may be beneficial for these people.[3]
  • Restrictive pulmonary diseases (i.e. pneumonia)[4]

Nervous system

  • Middle ear ossifications[4]
  • Hearing impairments[4]

Immune system

  • Flare-ups following viral infections can occur[4]
  • Inflammation[4]

Macrophages, lymphocytes, and mast cells will be present in early lesions of fibrodysplasia ossificans progressiva.[3]  

Renal system

  • Individuals with FOP are 2 times more likely to get kidney stones[3]
  • History of UTI, low fiber diet, and decreased water intake may also increase the risk of developing kidney stones in people with FOP.[3]

Integumentary system[5]

  • These individuals are at risk for pressure sores due to the decrease in soft tissue and the increase in bone.

Medical Management (current best evidence)[edit | edit source]

Medications[3] 

  • Reduces the pain and severity of flare-ups

Surgical release of joint contractures[3]

  • Usually unsuccessful

Osteotomy of heterotropic bone[3]

  • Mobilizes joints
  • Usually counterproductive because new heterotrophic ossificans can form at the site

Repositioned surgically[3]

  • Improves the patients overall functional status
  • Rare

Ultimately, there is not much that can be done to cure this disease.

Physical Therapy Management (current best evidence)[edit | edit source]

Physical therapy has been shown in some cases to make the condition worse in individuals with FOP because it tends to cause flare-ups which eventually leads to further ossification of the ligaments, tendons and muscle.[2] Aquatic therapy, however has been shown to be beneficial in maintaining ROM, pain relief, and aerobic endurance.[2] Aquatic therapy provides low impact and resistance created by the water which ultimately, enhances the ease of activities of daily living, makes functional activities as easy as possible, and implements fall prevention precautions.[2]

Differential Diagnosis[edit | edit source]

Fibrodysplasia Ossificans Progressiva has been commonly misdiagnosed by physicians with the following diseases:

  • Myositis Ossficians Progressiva
  • Juvenile Fibromatosis connective tissues cells called fibroblasts that invade ligaments, tendons and muscles causing swelling.[2] 
  • Lymphoedema
  • Soft tissue sarcomas/neoplasms there are many doctors that misdiagnose FOP for neoplasms due to the recurrence of soft tissue flare-ups.[2]

Case Reports/ Case Studies[edit | edit source]

  • 4 year old boy with FOP

Clinical and Genetic Analysis of Fibrodysplasia Ossificans Progressiva: A Case Report and Literature Review[1]

  • 20 year follow-up of a 23 year old female

A case of fibrodysplasia ossificans progressiva: 20 years of follow‑up[6]

  • 29 year old man with onset of sypmtoms at age 9

Fibrodysplasia ossificans progressiva without characteristic Skeletal anomalies[5]


Resources
[edit | edit source]

International Fibrodysplasia Ossificans Progressiva Association

There is a support group offered to individuals diagnosed with this disorder called Internation Fibrodysplasia Ossificans Progressiva Association. It discusses the latest research, what it is like to live with FOP, and clinical trials. It was founded by Jeannie Peeper who has FOP.  She wanted to end social isolation.[2]
IFOPA's "Mission of Hope" http://www.ifopa.org/component/content/article/33/105.html

http://www.ifopa.org/

Henry Eastlack Skeleton
Henry Eastlack was a gentlemen who suffered and died from FOP. His skeleton is now on display at The Mutter Museum of The College of Physicians in Philadelphia. When individuals die their skeleton falls apart because the connective tissue, ligaments and tendons are no longer holding their skeleton together. When a skeleton is put on display at a museum it has to meticulously be rearticulated with wires and glue. Henry's skeleton never had to be rearticulated becuase of the extra bone created by FOP.  His skeleton truly shows the harsh reality of FOP and the dysfunctions it can create.[2]

Fibrodysplasia Ossificans Progressiva

Recent Related Research (from Pubmed)[edit | edit source]


Failed to load RSS feed from http://www.ncbi.nlm.nih.gov/entrez/eutils/erss.cgi?rss_guid=1l1vNBYu_ed8RJFu0fy8kkxEfl4AejK35v1uT3QBf3SaP6zQF0|charset=UTF-8|short|max=10: Error parsing XML for RSS

References[edit | edit source]

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 Lakkireddy M, Chilakamarri V, Ranganath P, Arora A, Vanaja M. Clinical and Genetic Analysis of Fibrodysplasia Ossificans Progressiva: A Case Report and Literature Review. Journal Of Clinical &amp;amp;amp; Diagnostic Research [serial online]. August 2015;9(8):1-3. Available from: Academic Search Complete, Ipswich, MA. Accessed March 19, 2016.
  2. 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 2.11 2.12 2.13 2.14 2.15 International Fibrodysplasia Ossificans Progressiva Association. 2009. Available at: http://www.ifopa.org/. Accessed March 22, 2016.
  3. 3.00 3.01 3.02 3.03 3.04 3.05 3.06 3.07 3.08 3.09 3.10 3.11 3.12 3.13 3.14 Pignolo RJ, Shore EM, Kaplan FS. Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons. Pediatr Endocrinol Rev. 2013;10 Suppl 2:437-48.
  4. 4.0 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 Kaplan FS, Le merrer M, Glaser DL, et al. Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol. 2008;22(1):191-205.
  5. 5.0 5.1 5.2 Ulusoy H. Fibrodysplasia ossificans progressiva without characteristic skeletal anomalies. Rheumatol Int. 2012;32(5):1379-82.
  6. 6.0 6.1 6.2 Abhishek K, Jain S, Khadgawat R. A case of fibrodysplasia ossificans progressiva: 20 years of follow-up. Neurology India [serial online]. March 2016;64(2):354-356. Available from: Academic Search Complete, Ipswich, MA. Accessed March 22, 2016.